Abciximab

Abciximab bụ ọgwụ a na-eji agbanye ọgwụ mgbochi platelet n'ime akwara iji gbochie mkpụkọ ọbara n'ime ndị ọrịa na-eme ụfọdụ usoro obi dị oke egwu, ọkachasị ọgwụgwọ akwara obi (PCI). Dịka ihe na-egbochi glycoprotein IIb/IIIa receptor inhibitor, ọ na-egbochi platelet ịgbakọta, si otú a na-ebelata ihe ize ndụ nke nkụchi obi, strok, ma ọ bụ mkpọchi arịa ọbara n'oge na obere oge ka emechara usoro ndị a. Nduzi a na-ekpuchi ihe niile ịchọrọ ịma gbasara Abciximab, gụnyere ojiji ya, dose ya, mmetụta ya, mmekọrịta ya na uru ya.

Kedu ihe bụ Abciximab?

Abciximab bụ akụkụ monoclonal antibody (Fab) nke na-ejikọ na glycoprotein IIb/IIIa receptor na platelet, ụzọ ikpeazụ a na-ahụkarị maka nchịkọta platelet. Site na igbochi receptor a, Abciximab na-enyere aka belata ihe egwu nke mkpụkọ ọbara, ọkachasị na usoro obi dị oke egwu. A na-ejikarị ya eme ihe n'oge angioplasty na usoro ndị metụtara ya.

Ojiji nke Abciximab

A na-eji Abciximab mee ihe n'ụzọ bụ isi iji gbochie mkpụkọ mkpụkọ n'ime ntọala obi kpọmkwem. Isi ojiji gụnyere:

• N'oge Mmebi Ọrịa Coronary Percutaneous (PCI): A na-enyekarị Abciximab na ndị ọrịa na-enweta PCI, usoro iji mepee akwara akwara ma ọ bụ nke dị warara, iji belata ihe ize ndụ nke ịmepụta clot.
• Na nnukwu ọrịa coronary ọrịa (ACS): N'ọnọdụ nke ACS, ebe ọbara na-eruba na obi na-ebelata na mberede ma ọ bụ gbochie, Abciximab nwere ike ibelata ihe ize ndụ nke nkụchi obi.
• Ọgwụ mgbochi obi dị oke egwu: Maka ndị ọrịa nwere nnukwu ihe ize ndụ nke mmechi akwara mberede ma ọ bụ thrombosis.
• Ọrịa obi myocardial infarction (NSTEMI) ma ọ bụ ọrịa angina na-anaghị eguzo n'elu nke na-abụghị ST (Nnukwu ST): N'ime ndị ọrịa a na-eme atụmatụ maka PCI n'ime awa 24, iji belata ihe ize ndụ nke ihe omume obi ischemic.
• Njikwa PCI-Post-Post: A na-eji Abciximab eme ihe mgbe ụfọdụ dị ka ihe mgbochi dị mkpirikpi iji hụ na enweghị nsogbu ozugbo na-eso PCI ma ọ bụ usoro ndị yiri ya.

Usoro onunu ogwu nke Abciximab

Usoro onunu ogwu nke Abciximab dịgasị iche dabere na usoro na njirimara onye ọrịa. Ntuziaka usoro onunu ogwu a na-ahụkarị bụ ndị a:

• Ọgwụ mbụ Bolus: A na-enye otu ntụtụ bolus nke 0.25 mg/kg n'ime intravenously ihe dị ka nkeji iri ruo 10 tupu PCI.
• Usoro infusion: Mgbe bolus mbụ gasịrị, a na-enye 0.125 ?g/kg/min mgbe niile ruo awa iri na abụọ.

A na-ejikarị usoro ọgwụgwọ a eme ihe n'etiti ndị okenye na-anata PCI; agbanyeghị, usoro ọgwụgwọ nke ọ bụla nwere ike ịdị iche. Mgbanwe nwere ike ịdị mkpa dabere na ibu onye ọrịa, ọrụ akụrụ, na ihe egwu nke ọbara ọgbụgba. Ọ dị mkpa ịgbaso ntuziaka nke onye na-ahụ maka ahụike nke ọma mgbe ị na-eji Abciximab.

Kedu ka Abciximab si arụ ọrụ

Abciximab na-arụ ọrụ site n'igbochi platelet glycoprotein IIb/IIIa receptor, nke bụ nzọụkwụ ikpeazụ na nchịkọta platelet. Nke a na-egbochi fibrinogen na molekul ndị ọzọ na-arapara na platelet, si otú a na-ebelata mmepụta thrombus n'oge ọgwụgwọ akwara obi.

Mmetụta nke Abciximab

Dị ka ọgwụ niile, Abciximab nwere mmetụta ndị nwere ike ime. Mmetụta kachasị emetụta gụnyere:

Mmetụta emetụtakarị:

• Ọbara ọbara (karịsịa n'ebe a na-agba ọbara akwara)
• Nausea ma ọ bụ vomiting
• Hypotension
• Back mgbu

Mmetụta dị egwu:

• Ọbara ọgbụgba dị ukwuu: Karịsịa ọbara ọgbụgba afọ, intracranial, ma ọ bụ retroperitoneal.
• Thrombocytopenia: Enwere ike ibelata ọnụọgụ platelet nke ukwuu, mgbe ụfọdụ n'ime awa ole e nyere ya.
• Mmeghachi omume nfụkasị ahụ ma ọ bụ anaphylactic: Ọ dị obere mana o kwere omume, ọkachasị mgbe a na-ekpughe ya ugboro ugboro.

Ọ dị mkpa ịkọrọ onye na-ahụ maka ahụike gị ihe ọ bụla na-akpata ya, ọkachasị ma ọ bụrụ na ha siri ike ma ọ bụ na-adịgide.

Rịba ama: Ekwesighi inye Abciximab nye ndị ọrịa nwere ọbara ọgbụgba na-arụ ọrụ, ịwa ahụ n'oge na-adịbeghị anya, ma ọ bụ akụkọ ihe mere eme nke thrombocytopenia metụtara glycoprotein IIb/IIIa inhibitors.

Mmekọrịta na ọgwụ ndị ọzọ

Abciximab nwere ike iji ọgwụ ndị ọzọ na-emekọrịta ihe, nke nwere ike ịbawanye ohere nke mmetụta ma ọ bụ belata irè. Mkpakọrịta dị mkpa gụnyere:

• Anticoagulants na ọgwụ ndị ọzọ Antiplatelet: Mgbe ejikọtara ya na ọgwụ dị ka heparin, aspirin, ma ọ bụ clopidogrel, ihe ize ndụ nke ọbara ọgbụgba na-abawanye nke ukwuu. Achọrọ nlekota nso.
• Ọgwụ mgbochi mkpali na-adịghị steroidal (NSAIDs): NSAID dị ka ibuprofen nwere ike ịbawanye ohere ọbara ọgbụgba mgbe ejiri ya na Abciximab.
• Ọgwụ thrombolytic: Ọgwụ ndị na-agbaze mkpụkọ ọbara nwere ike iso Abciximab na-emekọrịta ihe, na-eduga n'ihe ize ndụ ọbara ọgbụgba.
• Ndị na-egbochi ACE na beta-blockers: Ọ bụ ezie na ọ bụghị iso Abciximab na-emekọrịta ihe ozugbo, ijikọta ndị a na Abciximab nwere ike ịbawanye ihe egwu hypotension.

Gwa onye na-ahụ maka ahụike gị oge niile ọgwụ ọ bụla ị na-aṅụ tupu ịmalite Abciximab.

Uru nke Abciximab

Nnyocha ahụike egosila na Acciximab na-ebelata ohere nke nsogbu ischemic, nkụchi obi, na mkpa ọ dị imegharị arịa ọbara ngwa ngwa n'ime ndị ọrịa na-aga PCI. Mgbe ejiri ya na aspirin na heparin, ọ na-eme ka usoro ọgwụgwọ dịkwuo mma ma na-eme ka ikike akwara obi dịkwuo mma.

Uru nke Acciximab, karịsịa maka ndị nwere nnukwu nsogbu obi, gụnyere:

• Na-ebelata ihe ize ndụ nke nkụchi obi n'oge PCI: Ojiji mbụ nke Acciximab bụ ibelata ihe egwu nke nkụchi obi n'oge PCI na ozugbo emechara ya.
• Na-ebelata ihe ize ndụ ọrịa strok: Site n'igbochi ime mkpụkọ, ọ nwere ike belata ohere nke ọrịa strok ischemic na ụfọdụ usoro obi obi.
• Na-eme ka ọnụ ahịa ịga nke ọma PCI: Site n'ibelata nhazi nke mkpụkọ, Abciximab na-enyere aka melite ọnụego ihe ịga nke ọma nke PCI.
• Nchekwa obere oge Post-PCI: Abciximab na-enye nchebe nwa oge na ngwa ngwa na-esote PCI, dị oke egwu maka ndị ọrịa nwere nnukwu ihe ize ndụ.
• A nabatara nke ọma na Ntọala ụlọ ọgwụ: Mgbe a na-elekọta ya n'okpuru nlekọta anya, Abciximab nwere ezigbo profaịlụ nchekwa maka ndị ọrịa nwere nnukwu ihe ize ndụ.

Ọtụtụ mgbe Ẹbụp Ajụjụ

Q1: Kedu ka esi enye Acciximab?

A: A na-enye Acciximab n'ime akwara, nke a na-ejikarị agba bolus, wee tinye ya n'ime akwara na-aga n'ihu n'oge usoro PCI.

Q2: Enwere ike iji Acciximab mee ihe n'ọgwụgwọ obi niile?

A: Mba, a na-enye Acciximab naanị maka ọgwụgwọ akwara obi na ikpe ACS ahọpụtara. A naghị akwado ya maka ọgwụgwọ antiplatelet ogologo oge.

Q3: Olee mgbe Acciximab ga-arụ ọrụ?

A: Acciximab na-amalite ịrụ ọrụ n'ime nkeji ole na ole nke e nyere ya, nke na-eme ka ọ dị irè nke ukwuu maka mgbochi mkpụkọ ọbara ozugbo n'oge usoro ọgwụgwọ.

Q4: Gịnị ka m ga-eme ma ọ bụrụ na m enweta mmetụta ọjọọ?

A: Kpọtụrụ onye na-ahụ maka ahụike gị ozugbo ma ọ bụrụ na ị nweta mmetụta dị ukwuu, ọkachasị ọbara ọgbụgba ma ọ bụ ihe ịrịba ama nke mmeghachi omume nfụkasị ahụ.

Q5: Enwere m ike iji Abciximab na ọgwụ ndị ọzọ na-eme ka ọbara dị gịrịgịrị?

A: Ijikọta Acciximab na ọgwụ ndị ọzọ na-eme ka ọbara gbaa mmadụ na-abawanye ohere nke ọbara ọgbụgba, yabụ ọ dị mkpa ịgbaso ntuziaka nke onye na-ahụ maka ahụike gị.

Q6: Ogologo oge ole ka mmetụta nke Acciximab ga-adịru?

A: Mmetụta nke Acciximab na-adịru ihe dị ka awa iri anọ na asatọ mgbe ọgwụ ahụ kwụsịrị, ọ bụ ezie na ọrụ platelet nwere ike ịmalite ịlaghachi ngwa ngwa. Ọrụ platelet na-alaghachikarị n'ọnọdụ kwesịrị ekwesị n'ime awa iri abụọ na anọ ruo iri anọ na asatọ mgbe ọgwụ ahụ kwụsịrị.

Q7: Ònye ekwesịghị ịṅụ Acciximab?

A: Ndị nwere ọbara ọgbụgba, ịwa ahụ ọhụrụ, ma ọ bụ ọbara mgbali elu dị oke njọ anaghị anabata Abciximab. Gakwuru onye na-ahụ maka ahụike mgbe niile maka ihe ndị a na-agaghị ekwe omume. A machibidoro ya maka ndị nwere ọbara ọgbụgba n'ime ahụ, nnukwu ịwa ahụ ma ọ bụ mmerụ ahụ n'oge na-adịbeghị anya, akụkọ ihe mere eme nke strok n'ime afọ 2, ọbara mgbali elu a na-achịkwaghị achịkwa, ma ọ bụ nnukwu thrombocytopenia.

Q8: Enwere mmachi nri ọ bụla mgbe ị na-aṅụ Acciximab?

A: Ọ bụ ezie na enweghị iwu nri a kapịrị ọnụ, izere mmanya na NSAID nwere ike inye aka belata ihe ize ndụ nke ọbara ọgbụgba. Gakwuru onye na-ahụ maka ahụike gị maka ndụmọdụ nkeonwe.

Q9: Enwere ike iji Acciximab mee ihe ogologo oge?

A: A na-ejikarị Acciximab eme ihe n'oge dị mkpirikpi, ọkachasị n'oge PCI na usoro ndị metụtara ya. Ojiji ogologo oge abụghị ihe a na-ahụkarị.

Q10: Kedu aha akara Acciximab?

A: A na-ere Abciximab n'aha ReoPro?. Enweghị ụdị nkịtị dị ugbu a.

mmechi

Abciximab bụ ọgwụ mgbochi glycoprotein IIb/IIIa nke a na-eji n'ime akwara, nke a na-eji eme ihe n'oge PCI iji gbochie nchịkọta platelet ma belata nsogbu ischemic. Mgbe a na-enye ya n'okpuru nlekọta ọkachamara, ọ na-enye nchebe nwa oge megide ihe omume thrombosis na ndị ọrịa nwere nnukwu ihe egwu. Agbanyeghị, n'ihi mmetụta antiplatelet dị ike ya, ọ nwere nnukwu ihe egwu ọbara ọgbụgba ma a ga-eji ya na nlekota anya nke ọma.